148 related articles for article (PubMed ID: 12651621)
1. Transglutaminase type II plays a protective role in hepatic injury.
Nardacci R; Lo Iacono O; Ciccosanti F; Falasca L; Addesso M; Amendola A; Antonucci G; Craxì A; Fimia GM; Iadevaia V; Melino G; Ruco L; Tocci G; Ippolito G; Piacentini M
Am J Pathol; 2003 Apr; 162(4):1293-303. PubMed ID: 12651621
[TBL] [Abstract][Full Text] [Related]
2. Tissue transglutaminase (TG2) acting as G protein protects hepatocytes against Fas-mediated cell death in mice.
Sarang Z; Molnár P; Németh T; Gomba S; Kardon T; Melino G; Cotecchia S; Fésüs L; Szondy Z
Hepatology; 2005 Sep; 42(3):578-87. PubMed ID: 16108039
[TBL] [Abstract][Full Text] [Related]
3. Transglutaminase 2 regulates mallory body inclusion formation and injury-associated liver enlargement.
Strnad P; Harada M; Siegel M; Terkeltaub RA; Graham RM; Khosla C; Omary MB
Gastroenterology; 2007 Apr; 132(4):1515-26. PubMed ID: 17408647
[TBL] [Abstract][Full Text] [Related]
4. Tissue transglutaminase does not affect fibrotic matrix stability or regression of liver fibrosis in mice.
Popov Y; Sverdlov DY; Sharma AK; Bhaskar KR; Li S; Freitag TL; Lee J; Dieterich W; Melino G; Schuppan D
Gastroenterology; 2011 May; 140(5):1642-52. PubMed ID: 21277850
[TBL] [Abstract][Full Text] [Related]
5. Transglutaminase 2 deficiency decreases plaque fibrosis and increases plaque inflammation in apolipoprotein-E-deficient mice.
Van Herck JL; Schrijvers DM; De Meyer GR; Martinet W; Van Hove CE; Bult H; Vrints CJ; Herman AG
J Vasc Res; 2010; 47(3):231-40. PubMed ID: 19893320
[TBL] [Abstract][Full Text] [Related]
6. Transglutaminase 2 limits murine peritoneal acute gout-like inflammation by regulating macrophage clearance of apoptotic neutrophils.
Rose DM; Sydlaske AD; Agha-Babakhani A; Johnson K; Terkeltaub R
Arthritis Rheum; 2006 Oct; 54(10):3363-71. PubMed ID: 17009310
[TBL] [Abstract][Full Text] [Related]
7. Transglutaminase 2 exacerbates experimental autoimmune encephalomyelitis through positive regulation of encephalitogenic T cell differentiation and inflammation.
Oh K; Park HB; Seo MW; Byoun OJ; Lee DS
Clin Immunol; 2012 Nov; 145(2):122-32. PubMed ID: 23001131
[TBL] [Abstract][Full Text] [Related]
8. Intimal hyperplasia in loop-injured carotid arteries is attenuated in transglutaminase 2-null mice.
Min SK; Min SI; Jeong EM; Cho SY; Ha J; Kim SJ; Kim IG
J Korean Med Sci; 2014 Mar; 29(3):363-9. PubMed ID: 24616585
[TBL] [Abstract][Full Text] [Related]
9. Transglutaminase 2 modulates antigen-specific antibody response by suppressing Blimp-1 and AID expression of B cells in mice.
Kim JH; Jeong EM; Jeong YJ; Lee WJ; Kang JS; Kim IG; Hwang YI
Immunol Lett; 2012 Sep; 147(1-2):18-28. PubMed ID: 22658978
[TBL] [Abstract][Full Text] [Related]
10. Some lessons from the tissue transglutaminase knockout mouse.
Sarang Z; Tóth B; Balajthy Z; Köröskényi K; Garabuczi E; Fésüs L; Szondy Z
Amino Acids; 2009 Apr; 36(4):625-31. PubMed ID: 18584284
[TBL] [Abstract][Full Text] [Related]
11. The role of tissue transglutaminase (TG2) in regulating the tumour progression of the mouse colon carcinoma CT26.
Kotsakis P; Wang Z; Collighan RJ; Griffin M
Amino Acids; 2011 Oct; 41(4):909-21. PubMed ID: 21046178
[TBL] [Abstract][Full Text] [Related]
12. Tissue transglutaminase activity is involved in the differentiation of oligodendrocyte precursor cells into myelin-forming oligodendrocytes during CNS remyelination.
Van Strien ME; Baron W; Bakker EN; Bauer J; Bol JG; Brevé JJ; Binnekade R; Van Der Laarse WJ; Drukarch B; Van Dam AM
Glia; 2011 Nov; 59(11):1622-34. PubMed ID: 21818782
[TBL] [Abstract][Full Text] [Related]
13. Hepatitis C virus (HCV) protein expression enhances hepatic fibrosis in HCV transgenic mice exposed to a fibrogenic agent.
Chouteau P; Defer N; Florimond A; Caldéraro J; Higgs M; Gaudin A; Mérour E; Dhumeaux D; Lerat H; Pawlotsky JM
J Hepatol; 2012 Sep; 57(3):499-507. PubMed ID: 22613003
[TBL] [Abstract][Full Text] [Related]
14. Transglutaminase 2 strongly binds to an extracellular matrix component other than fibronectin via its second C-terminal beta-barrel domain.
Stamnaes J; Cardoso I; Iversen R; Sollid LM
FEBS J; 2016 Nov; 283(21):3994-4010. PubMed ID: 27685605
[TBL] [Abstract][Full Text] [Related]
15. Tissue-specific responses to loss of transglutaminase 2.
Deasey S; Shanmugasundaram S; Nurminskaya M
Amino Acids; 2013 Jan; 44(1):179-87. PubMed ID: 22194042
[TBL] [Abstract][Full Text] [Related]
16. Transglutaminase type II is a key element in the regulation of the anti-inflammatory response elicited by apoptotic cell engulfment.
Falasca L; Iadevaia V; Ciccosanti F; Melino G; Serafino A; Piacentini M
J Immunol; 2005 Jun; 174(11):7330-40. PubMed ID: 15905580
[TBL] [Abstract][Full Text] [Related]
17. Transglutaminase 2 silencing reduced the beta-amyloid-effects on the activation of human THP-1 cells.
Currò M; Ferlazzo N; Condello S; Caccamo D; Ientile R
Amino Acids; 2010 Nov; 39(5):1427-33. PubMed ID: 20437185
[TBL] [Abstract][Full Text] [Related]
18. Endostatin and transglutaminase 2 are involved in fibrosis of the aging kidney.
Lin CH; Chen J; Zhang Z; Johnson GV; Cooper AJ; Feola J; Bank A; Shein J; Ruotsalainen HJ; Pihlajaniemi TA; Goligorsky MS
Kidney Int; 2016 Jun; 89(6):1281-92. PubMed ID: 27165830
[TBL] [Abstract][Full Text] [Related]
19. In vivo evaluation of type 2 transglutaminase contribution to the metastasis formation in melanoma.
Di Giacomo G; Lentini A; Beninati S; Piacentini M; Rodolfo C
Amino Acids; 2009 Apr; 36(4):717-24. PubMed ID: 18594948
[TBL] [Abstract][Full Text] [Related]
20. Complete transglutaminase 2 ablation results in reduced stroke volumes and astrocytes that exhibit increased survival in response to ischemia.
Colak G; Johnson GV
Neurobiol Dis; 2012 Mar; 45(3):1042-50. PubMed ID: 22198379
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
